119 related articles for article (PubMed ID: 37181365)
1. Factors associated with
Jiang Y; Chen J; Ying M; Liu L; Li M; Lu S; Li Z; Zhang P; Xie Q; Liu X; Lu H
Front Med (Lausanne); 2023; 10():1136094. PubMed ID: 37181365
[TBL] [Abstract][Full Text] [Related]
2. "Better to Die Than Take These Medicines": A Community-Based Qualitative Study on the Determinants of Treatment Loss-to-Follow-Up in Tuberculosis Patients in District Faridabad, Haryana, India.
Khaitan A; Rai SK; Krishnan A; Gupta SK; Kant S; Khilnani GC
Cureus; 2022 May; 14(5):e25030. PubMed ID: 35591891
[TBL] [Abstract][Full Text] [Related]
3. Incidence and predictors of lost to follow-up among drug-resistant tuberculosis patients at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia: a retrospective follow-up study.
Kassa GM; Teferra AS; Wolde HF; Muluneh AG; Merid MW
BMC Infect Dis; 2019 Sep; 19(1):817. PubMed ID: 31533661
[TBL] [Abstract][Full Text] [Related]
4. Loss to follow-up among patients diagnosed with spinal tuberculosis at a tertiary hospital in Western Cape Province, South Africa: A retrospective cohort study.
Mann TN; Davis JH; Dyers R
S Afr Med J; 2020 Mar; 110(4):284-290. PubMed ID: 32657739
[TBL] [Abstract][Full Text] [Related]
5. The Effect of Timing of Initiation of Antiretroviral Therapy on Loss to Follow-up in HIV-Tuberculosis Coinfected Patients in South Africa: An Open-Label, Randomized, Controlled Trial.
Yende-Zuma N; Naidoo K
J Acquir Immune Defic Syndr; 2016 Aug; 72(4):430-6. PubMed ID: 26990824
[TBL] [Abstract][Full Text] [Related]
6. Loss to follow-up among patients receiving anti-tuberculosis treatment, Haiti, 2011-2015.
Schnaubelt ER; Charles M; Richard M; Fitter DL; Morose W; Cegielski JP
Public Health Action; 2018 Dec; 8(4):154-161. PubMed ID: 30775274
[No Abstract] [Full Text] [Related]
7. Isoniazid mono-resistant tuberculosis: Time to take it seriously.
Garg K; Saini V; Dhillon R; Agarwal P
Indian J Tuberc; 2019 Apr; 66(2):247-252. PubMed ID: 31151492
[TBL] [Abstract][Full Text] [Related]
8. Microbiologically Confirmed Tuberculosis: Factors Associated with Pre-Treatment Loss to Follow-Up, and Time to Treatment Initiation.
Mwansa-Kambafwile J; Maitshotlo B; Black A
PLoS One; 2017; 12(1):e0168659. PubMed ID: 28068347
[TBL] [Abstract][Full Text] [Related]
9. Machine learning algorithms using national registry data to predict loss to follow-up during tuberculosis treatment.
Rodrigues MMS; Barreto-Duarte B; Vinhaes CL; Araújo-Pereira M; Fukutani ER; Bergamaschi KB; Kristki A; Cordeiro-Santos M; Rolla VC; Sterling TR; Queiroz ATL; Andrade BB
BMC Public Health; 2024 May; 24(1):1385. PubMed ID: 38783264
[TBL] [Abstract][Full Text] [Related]
10. Determinant factors for loss to follow-up in drug-resistant tuberculosis patients: the importance of psycho-social and economic aspects.
Soedarsono S; Mertaniasih NM; Kusmiati T; Permatasari A; Juliasih NN; Hadi C; Alfian IN
BMC Pulm Med; 2021 Nov; 21(1):360. PubMed ID: 34758794
[TBL] [Abstract][Full Text] [Related]
11. Predictors of loss to follow-up among adult tuberculosis patients in Southern Ethiopia: a retrospective follow-up study.
Watumo D; Mengesha MM; Gobena T; Gebremichael MA; Jerene D
BMC Public Health; 2022 May; 22(1):976. PubMed ID: 35568853
[TBL] [Abstract][Full Text] [Related]
12. Retreatment after loss to follow-up reduces mortality in patients with multidrug/rifampicin-resistant tuberculosis.
Choi H; Mok J; Ae Kang Y; Jeong D; Kang HY; Kim HJ; Kim HS; Jeon D
ERJ Open Res; 2023 Jul; 9(4):. PubMed ID: 37583964
[TBL] [Abstract][Full Text] [Related]
13. Tuberculosis cohort analysis in Zimbabwe: The need to strengthen patient follow-up throughout the tuberculosis care cascade.
Mando TC; Sandy C; Chadambuka A; Gombe NT; Juru TP; Shambira G; Umeokonkwo CD; Tshimanga M
PLoS One; 2023; 18(11):e0293867. PubMed ID: 37939099
[TBL] [Abstract][Full Text] [Related]
14. TB treatment non-adherence in São Tomé and Príncipe.
Bandeira S; da Trindade S; Raguenaud ME; Sousa B
Public Health Action; 2022 Dec; 12(4):195-200. PubMed ID: 36561905
[TBL] [Abstract][Full Text] [Related]
15. FACTORS CONTRIBUTING TO PULMONARY TB TREATMENT LOST TO FOLLOW-UP IN DEVELOPING COUNTRIES: AN OVERVIEW.
Monique O; Ilse DP
Afr J Infect Dis; 2023; 17(1):60-73. PubMed ID: 36756489
[TBL] [Abstract][Full Text] [Related]
16. Low BMI increases all-cause mortality rates in patients with drug-resistant TB.
Adamashvili N; Baliashvili D; Kuchukhidze G; Salindri AD; Kempker RR; Blumberg HM; Lomtadze N; Avaliani Z; Magee MJ
Int J Tuberc Lung Dis; 2022 Apr; 26(4):326-333. PubMed ID: 35351237
[TBL] [Abstract][Full Text] [Related]
17. Treatment outcomes among children, adolescents, and adults on treatment for tuberculosis in two metropolitan municipalities in Gauteng Province, South Africa.
Berry KM; Rodriguez CA; Berhanu RH; Ismail N; Mvusi L; Long L; Evans D
BMC Public Health; 2019 Jul; 19(1):973. PubMed ID: 31331311
[TBL] [Abstract][Full Text] [Related]
18. Incidence and predictors of LTFU among adults with TB/HIV co-infection in two governmental hospitals, Mekelle, Ethiopia, 2009-2016: survival model approach.
Gezae KE; Abebe HT; Gebretsadik LG
BMC Infect Dis; 2019 Feb; 19(1):107. PubMed ID: 30717705
[TBL] [Abstract][Full Text] [Related]
19. [Loss to follow-up in patients treated for multidrug-resistant tuberculosis in EcuadorA Perda de seguimento de pacientes tratados para tuberculose multirresistente a medicamentos no Equador].
Tatés-Ortega N; Álvarez J; López L; Mendoza-Ticona A; Alarcón-Arrascue E
Rev Panam Salud Publica; 2019; 43():e91. PubMed ID: 31892925
[TBL] [Abstract][Full Text] [Related]
20. Loss to follow-up before and after initiation of antiretroviral therapy in HIV facilities in Lilongwe, Malawi.
Tweya H; Oboho IK; Gugsa ST; Phiri S; Rambiki E; Banda R; Mwafilaso J; Munthali C; Gupta S; Bateganya M; Maida A
PLoS One; 2018; 13(1):e0188488. PubMed ID: 29373574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
